Cardinal Health, Inc. $CAH Shares Sold by Swiss Life Asset Management Ltd

Swiss Life Asset Management Ltd reduced its position in Cardinal Health, Inc. (NYSE:CAH) by 9.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 69,381 shares of the company’s stock after selling 7,355 shares during the period. Swiss Life Asset Management Ltd’s holdings in Cardinal Health were worth $14,258,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the company. Redhawk Wealth Advisors Inc. increased its position in Cardinal Health by 0.5% during the fourth quarter. Redhawk Wealth Advisors Inc. now owns 9,255 shares of the company’s stock worth $1,902,000 after buying an additional 48 shares during the period. HF Advisory Group LLC lifted its stake in Cardinal Health by 0.9% in the fourth quarter. HF Advisory Group LLC now owns 5,227 shares of the company’s stock valued at $1,074,000 after buying an additional 49 shares during the last quarter. Generali Asset Management SPA SGR boosted its holdings in shares of Cardinal Health by 11.0% in the fourth quarter. Generali Asset Management SPA SGR now owns 513 shares of the company’s stock valued at $105,000 after acquiring an additional 51 shares during the period. Latitude Advisors LLC boosted its holdings in shares of Cardinal Health by 2.1% in the third quarter. Latitude Advisors LLC now owns 2,598 shares of the company’s stock valued at $408,000 after acquiring an additional 53 shares during the period. Finally, Barnes Dennig Private Wealth Management LLC grew its position in shares of Cardinal Health by 38.7% during the fourth quarter. Barnes Dennig Private Wealth Management LLC now owns 190 shares of the company’s stock worth $39,000 after acquiring an additional 53 shares during the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Price Performance

Cardinal Health stock opened at $182.63 on Tuesday. Cardinal Health, Inc. has a 12 month low of $137.75 and a 12 month high of $233.60. The business has a 50 day simple moving average of $209.97 and a 200-day simple moving average of $207.30. The stock has a market capitalization of $42.77 billion, a PE ratio of 27.93, a price-to-earnings-growth ratio of 1.09 and a beta of 0.53.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. The firm had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. Cardinal Health’s quarterly revenue was up 11.0% on a year-over-year basis. During the same period last year, the firm posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities research analysts anticipate that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a dividend of $0.5158 per share. This represents a $2.06 dividend on an annualized basis and a dividend yield of 1.1%. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 31.19%.

Wall Street Analyst Weigh In

CAH has been the topic of a number of recent research reports. Jefferies Financial Group lifted their target price on shares of Cardinal Health from $220.00 to $270.00 and gave the company a “buy” rating in a report on Thursday, January 22nd. Leerink Partners reissued an “outperform” rating and set a $275.00 price objective on shares of Cardinal Health in a research report on Monday, March 9th. Citigroup lowered their price objective on shares of Cardinal Health from $249.00 to $245.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. JPMorgan Chase & Co. reduced their target price on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a report on Monday, May 4th. Finally, Evercore decreased their target price on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research note on Wednesday, April 8th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $241.80.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.